Revvity | PKI - Interest Income


Revvity reported $0.4 in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Agilent USD 17M 1000K Sep/2025
Align Technology USD 3.25M 390K Sep/2025
Bio Techne USD 971K 386K Sep/2025
Bio-Rad Laboratories USD 13.7M 1000K Sep/2025
Bruker USD 4.4M 1.5M Sep/2025
Celltrion KRW 676.66M 6.85B Jun/2025
Charles River Laboratories USD 1.1 1.1M Sep/2025
Danaher USD 1.27 8M Sep/2025
Dentsply International USD 4M 1000K Mar/2025
Dianthus Therapeutics USD 3.66M 255K Sep/2025
Edwards Lifesciences USD 38.6M 1.2M Sep/2025
Exact Sciences USD -5.29 5.08 Dec/2024
Hologic USD 0.79 18.9M Dec/2025
Illumina USD 0.98 10M Sep/2025
Intuitive Surgical USD 95.5M 6.8M Sep/2025
IQVIA Holdings USD 13M 3M Sep/2025
Kangmei Pharma CNY 1.81M 2.5M Jun/2025
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma EUR 139K 42K Jun/2025
Medical Developments International AUD 174K 31K Dec/2024
Myriad Genetics USD 300K 0 Mar/2025
Pharma Mar EUR 4.8M 6.4M Dec/2024
Qiagen NV USD 15.07M 1.21M Sep/2025
Quest Diagnostics USD 3M 1000K Sep/2025
Quidel USD -10.78 600.01K Sep/2025
Repligen USD 7.31M 979K Mar/2025
Revvity USD 0.4 8.34M Sep/2025
Sartorius EUR 54.9M 77.1M Mar/2025
Thermo Fisher Scientific USD 4.27 297M Sep/2025
Tilray USD 12.83M 20.19M May/2024
Waters USD 2.5 4.51M Sep/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 6.65M 4.01M Jun/2025